Status:

NOT_YET_RECRUITING

The Research Team Aims to Elucidate the Impact of ITBS (intermittent Theta Burst Stimulation) on the HPA Axis and Post-stroke Negative Emotions/depression by Conducting Human Experiments That Target Various Brain Regions.

Lead Sponsor:

The Second Affiliated Hospital of Kunming Medical University

Conditions:

Stroke

Post-stroke Depression

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

The project team will categorize stroke patients into three groups receiving iTBS stimulation targeting distinct brain regions: the cerebellum, the dorsolateral prefrontal cortex (DLPFC), and the prim...

Eligibility Criteria

Inclusion

  • Initial stroke onset \<6 months, or the last stroke event occurred more than 6 months ago;
  • Age ≥18 years, \<85 years (the likelihood of VCI increases beyond 85 years);
  • Patients with lesions in the middle cerebral artery region;
  • NIHSS \>4, NIHSS \<26;
  • mRS score ≥2;
  • Completion of CT or MRI;
  • No severe neurological or psychiatric disorders; no impairment of consciousness, able to cooperate with relevant treatments; no severe cognitive impairment (MMSE ≥15);
  • All participants are right-handed;
  • Signed informed consent form.

Exclusion

  • History of epilepsy or psychiatric disorders (including depression, anxiety, or schizophrenia);
  • Severe comorbidities;
  • History of medication use: benzodiazepines, baclofen, or antidepressants;
  • Non-compliance with the protocol;
  • Acute phase of cerebral hemorrhage or acute infectious diseases;
  • Severe suicidal tendencies in patients with depression;
  • Severe headache, hypertension, malignant tumors, open wounds, vascular embolism, leukopenia, or other serious conditions;
  • Severe alcohol abuse;
  • History of cranial surgery or presence of metal implants in the brain;
  • Patients with cardiac pacemakers;
  • NIHSS \> 26 or MMSE \< 15;
  • Any condition likely to result in the patient's survival for less than 1 month;
  • Pregnancy.

Key Trial Info

Start Date :

April 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 30 2027

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06899893

Start Date

April 1 2025

End Date

July 30 2027

Last Update

March 28 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.